The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
“Sutures? That’s practically medieval!” It is a staple of science fiction to mock sutures as outdated. After all, the technique has been in use for at least 5,000 years. Professor Hossam Haick from the Wolfson Department of Chemical Engineering at the Technion has finally turned science fiction into reality. His lab created a smart, sutureless dressing that binds the wound together, wards off infection, and reports on the wound’s condition directly to the doctors’ computers. “I was watching a movie on futuristic robotics with my kids late one night,” said Prof. Haick, “and I thought, what if we could really…
The technology, based on the Nano-Ghosts platform, makes it possible to reduce the drug dose a million-fold without reducing its efficacy. Researchers in the Faculty of Biotechnology and Food Engineering at the Technion developed a technology that inhibits development of melanoma using one-millionth of the active ingredient. The study, published in Advanced Functional Materials, was led by Professor Marcelle Machluf, dean of the faculty, and Ph.D. student Lior Levy. This development is a significant breakthrough in the field of immunotherapy — an innovative medical approach that uses the body’s own immune system to destroy cancer cells. Immunotherapy can destroy cancer…
Researchers at the Technion – Israel Institute of Technology, in collaboration with researchers from Le Centre National de la Recherche Scientifique (CNRS) in Toulouse, France, discovered an artificial molecule that may inhibit the development of Alzheimer’s disease. The molecule breaks down the toxic chemical complex Cu–Aβ, inhibiting the cell death that is thought to be related to Alzheimer’s. The study was led by Professor Galia Maayan and doctoral student Anastasia Behar from the Schulich Faculty of Chemistry, in collaboration with Professor Christelle Hureau from the Laboratoire de Chimie de Coordination du CNRS.
A new algorithm developed by the Technion – Israel Institute of Technology helps doctors select more effective, personalized antibiotic treatments for patients. After doctors at Maccabi Healthcare Services adopted the algorithm for patients with urinary tract infections (UTIs), they saw a 35% drop in the need to switch a patient’s antibiotic regimen. Maccabi first applied the algorithm to patients with urinary tract infections (UTIs) – the most common bacterial infection among women. Around 30% of women suffer from UTIs at least once during their lifetimes, and up to 10% experience recurrent infections. Until now, in most cases general treatment has…
A friend calls with the news she was just diagnosed with COVID-19. You had dinner with her last night, and suddenly you start coughing, feel flu-like symptoms, and your fever spikes. What’s going on? Are you coming down with the virus or are your symptoms psychosomatic? You test negative. Yet Technion Associate Professor Asya Rolls […]
Technion – Israel Institute of Technology Assistant Professor Assaf Zinger and Dr. Caroline Cvetkovic from the Center for Neuroregeneration at the Houston Methodist Research Institute have created a novel means of delivering medicine to neurons in a targeted manner. The biomimetic nano-vesicles, or nature-mimicking, nanometer-scale “vehicles,” are capable of specifically targeting neurons such as nerve cells. These nano-vehicles pave the way for the treatment of multiple neurodegenerative diseases and traumatic brain injuries.
Pictured above: Professor Shulamit Levenberg (Left) and Ph.D. student Rita Beckerman The Technion has developed a novel approach to treat type 2 diabetes. Led by Professor Shulamit Levenberg and Ph.D. student Rita Beckerman, the treatment uses an autograft of muscle cells engineered to take in sugar at increased rates. Mice treated in this manner displayed normal blood sugar levels for months after a single procedure. Prof. Levenberg is the director of the Rina & Avner Schneur Center for Diabetes Research and the Technion Center for 3D Bioprinting, and holds the Stanley and Sylvia Shirvan Chair in Cancer and Life Sciences…
There is no guarantee for preventing stroke, but eating healthy, exercising, and regular medical check-ups go a long way. Now it seems we can reduce stroke risks even more with computer science. Two Technion master’s degree students have written a machine learning algorithm that can accurately predict whether a person will develop the irregular heart rhythm atrial fibrillation (AFib) — a condition that causes one in seven strokes. Working under the supervision of Assistant Professor Joachim A. Behar, head of the Artificial Intelligence Laboratory in Medicine, Shany Biton and Sheina Gendelman accessed more than one million ECG recordings from more…
Guiding a medical needle through the body to do biopsies and other treatment is not an easy task. Straight needles work when the path is a straight shot, but often the target is hidden behind bones or vulnerable tissue. In recent years scientists have developed medical needles with beveled tips and algorithms to direct the needles, but the procedure is still risky. Now a team from the Technion and the University of North Carolina have developed a new algorithm that hopes to make the task safer and more precise.